NKX2-8 and breast carcinoma: Moreover, we found that treatment with all three PTHrP inhibitor exhibited dramatic blocked effect on vicious cycle induced by silencing NKX2-8, as indicated by decreased level of bone matrix-released TGF-β1 and slower growth rates of breast cancer cells (Supplementary Figure 4).